AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 16 filers reported holding AMRYT PHARMA PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 3.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $16,629,137 | +5.5% | 2,277,964 | 0.0% | 0.18% | +0.6% |
| Q3 2022 | $15,764,000 | -1.0% | 2,277,964 | 0.0% | 0.18% | +23.9% |
| Q2 2022 | $15,923,000 | -15.5% | 2,277,964 | 0.0% | 0.14% | -6.0% |
| Q1 2022 | $18,839,000 | -23.4% | 2,277,964 | 0.0% | 0.15% | -19.7% |
| Q4 2021 | $24,602,000 | -10.3% | 2,277,964 | 0.0% | 0.19% | -11.3% |
| Q3 2021 | $27,438,000 | -0.7% | 2,277,964 | 0.0% | 0.21% | +1.0% |
| Q2 2021 | $27,632,000 | -13.5% | 2,277,964 | -0.6% | 0.21% | -16.3% |
| Q1 2021 | $31,930,000 | +13.2% | 2,292,164 | +15.1% | 0.25% | 0.0% |
| Q4 2020 | $28,196,000 | -0.5% | 1,991,259 | -13.2% | 0.25% | -20.3% |
| Q3 2020 | $28,344,000 | – | 2,293,180 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,857,268 | $61,292,000 | 22.96% |
| Stonepine Capital Management, LLC | 6,227,733 | $43,096,000 | 19.37% |
| MPM ASSET MANAGEMENT LLC | 2,668,843 | $18,468,000 | 7.03% |
| Aquilo Capital Management, LLC | 1,998,993 | $13,833,000 | 4.99% |
| New Leaf Venture Partners, L.L.C. | 449,737 | $3,112,000 | 1.85% |
| Global Frontier Investments LLC | 505,000 | $3,495,000 | 1.77% |
| Rubric Capital Management LP | 3,600,000 | $24,912,000 | 1.26% |
| Telemetry Investments, L.L.C. | 123,000 | $851,000 | 1.09% |
| Nantahala Capital Management | 1,437,458 | $9,947,000 | 0.64% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,333,552 | $43,828,000 | 0.62% |